Press Release

Revive Therapeutics Acquires Unique Psilocybin Assets

The biosynthetic platform developed by Dr. Gavin Williams provides a potential simple and efficient method for rapidly producing natural products, such as psilocybin, using an engineered enzymatic pathway in E. coli.

News Archive

Email Sign Up

Please confirm your consent to receive electronic communications from Revive Therapeutics by entering your email address and clicking the button below.